Advertisement

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Chandini M. Thirukkumaran, Zhong Qiao Shi, Gerard J. Nuovo, Joanne Luider, Karen A. Kopciuk, Yuan Dong, Ahmed A. Mostafa, Satbir Thakur, Kathy Gratton, Ailian Yang, Alex C. Chin, Matt C. Coffey, Victor H. Jimenez-Zepeda, Douglas Stewart, Marta Chesi, P. Leif Bergsagel and Don Morris

Article Information

Citation 
vol. 3 no. 5 797-812
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 3, 2018
  • Accepted January 14, 2019
  • Published online March 8, 2019.


Contributors 
  • Chandini M. Thirukkumaran, 1Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Zhong Qiao Shi, 1Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Gerard J. Nuovo, 2Ohio State University Comprehensive Cancer Center, Ohio State University, Columbus, OH;3Phylogeny Inc., Powell, OH;
  • Joanne Luider, 4Flow Cytometry Laboratory, Department of Pathology and Laboratory Medicine, Alberta Public Laboratories, Calgary, AB, Canada;
  • Karen A. Kopciuk, 5Cancer Control, Department of Cancer Epidemiology and Prevention Research, Alberta Health Services,6Department of Mathematics and Statistics,7Department of Oncology, and8Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada;
  • Yuan Dong, 6Department of Mathematics and Statistics,
  • Ahmed A. Mostafa, 9Histocompatibility and Immunogenetics Laboratory, Department of Pathology and Laboratory Medicine, Alberta Public Laboratories, Calgary, AB, Canada;
  • Satbir Thakur, 1Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Kathy Gratton, 10Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Ailian Yang, 1Translational Research Laboratories, Tom Baker Cancer Centre, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Alex C. Chin, 11Clinical Section of Clinical Biochemistry, Alberta Public Laboratories, Calgary, AB, Canada;12Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada;
  • Matt C. Coffey, 13Oncolytics Biotech, Calgary, AB, Canada;
  • Victor H. Jimenez-Zepeda, 14Division of Hematology, Department of Medicine, and
  • Douglas Stewart, 15Division of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; and
  • Marta Chesi, 16Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ
  • P. Leif Bergsagel, 16Division of Hematology/Oncology, Department of Medicine, Mayo Clinic, Scottsdale, AZ
  • Don Morris, 15Division of Medical Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; and

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output